Qsymia is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Vivus, Inc.. The primary component is Phentermine Hydrochloride; Topiramate.
| Product ID | 62541-204_7abbdebd-dd3f-53ba-e053-2a91aa0adbbf |
| NDC | 62541-204 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Qsymia |
| Generic Name | Phentermine And Topiramate |
| Dosage Form | Capsule, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-09-17 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022580 |
| Labeler Name | Vivus, Inc. |
| Substance Name | PHENTERMINE HYDROCHLORIDE; TOPIRAMATE |
| Active Ingredient Strength | 15 mg/1; mg/1 |
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA],Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2012-09-17 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022580 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-09-17 |
| Ingredient | Strength |
|---|---|
| PHENTERMINE HYDROCHLORIDE | 15 mg/1 |
| SPL SET ID: | 40dd5602-53da-45ac-bb4b-15789aba40f9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 62541-201 | Qsymia | phentermine and topiramate |
| 62541-202 | Qsymia | phentermine and topiramate |
| 62541-203 | Qsymia | phentermine and topiramate |
| 62541-204 | Qsymia | phentermine and topiramate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() QSYMIA 85656775 4295224 Live/Registered |
Vivus, Inc. 2012-06-20 |